FXH - First Trust Health Care AlphaDEX ETF
| Previous Close | 67.89 |
| Open | 68.01 |
| Bid | 67.40 x 1300 |
| Ask | 68.36 x 1200 |
| Day's Range | 67.82 - 68.31 |
| 52 Week Range | 54.51 - 69.24 |
| Volume | 115,794 |
| Avg. Volume | 79,310 |
| Net Assets | 1.04B |
| NAV | 67.45 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Return | 17.66% |
| Beta (3y) | 0.89 |
| Expense Ratio (net) | 0.61% |
| Inception Date | 2007-05-08 |
- Business Wire•7 days ago
Four Additional First Trust ETFs Approved for Sale in Mexican Pension Plans
First Trust Advisors L.P. a global exchange-traded fund provider and asset manager, announced that the Mexican pension funds investment regulator, La Comisión Nacional del Sistema de Ahorro para el Retiro , has approved four additional First Trust ETFs for sale to Mexican funded pensions, known as AFORES.
- Barrons.com•29 days ago
ETF Flopper: Repeal and Replace Revived, Sinks Health-Care Stocks
Health-care stocks finished dead last in the Standard & Poor's 500 as Republicans tried yet again to repeal and replace the Affordable Care Act. The Cassidy-Graham bill, named for Senator Bill Cassidy, R-La., and Lindsey Graham, R-S.C., was introduced Sept. 13 and appears to be gaining momentum. Cassidy-Graham would get rid of individual and employer mandates and subsidies and rollback Medicaid, among other things.
- Market Realist•2 months ago
How United Therapeutics’ Remodulin and Tyvaso Are Performing
In 2Q17, United Therapeutics’ (UTHR) Remodulin generated revenues of around $158 million, which reflected ~8% growth on a quarter-over-quarter basis.
- Market Realist•3 months ago
Abiomed in 2017: The Analysts’ View
For the quarter ending March 31, 2017, Abiomed (ABMD) reported revenues close to $124.7 million, which represents a YoY growth of about 30%.
- Market Realist•4 months ago
Inside Align Technology’s Robust Revenue Growth Projection for 2017
For fiscal 2017, Align Technology (ALGN) expects its 2017 revenues to grow operationally in the range of 15%–25% YoY.
- Market Realist•5 months ago
WellCare Health Plans Expected to Report Solid Rise in EPS in 2017
WellCare Health Plans has updated its earnings per share guidance from the previously estimated range of $6.00–$6.25 to the new range of $6.55–$6.80.
- Market Realist•5 months ago
How Dentsply Sirona’s Profitability Metrics Looked in 1Q17
Dentsply Sirona’s (XRAY) 1Q17 earnings and revenue failed to meet analysts’ estimates. The company reported a fall in its organic revenue.
- Zacks•5 months ago
Sector ETFs to Win on Strong April Job Data
Bet on the ETFs of sectors that added solid jobs in the month of April and strengthened the month's data.
- Market Realist•7 months ago
Which Hospital Stocks Are Expected to Benefit Most?
Trumpcare's failure is considered to be a boon by hospital companies treating a significant portion of Medicaid members.
- Zacks•7 months ago
Healthcare ETFs in Focus on Obamacare Replacement Plan
House Republicans have released the long-awaited bill to repeal and replace Obama's signature healthcare law last evening. This will unwind much of the law over the next three years.
- Market Realist•8 months ago
Performance of Incyte’s Jakafi in the United States
Revenues for Jakafi rose more than 42.0% to $852.8 million in 2016, from $601.0 million in 2015.
- Zacks•8 months ago
Trump Set for Maiden Speech to Congress: ETFs in Focus
The President is expected to bring more clarity on promised tax cuts, big spending, and other business friendly policies in his first speech to Congress slated to be held later today.
- Market Realist•9 months ago
How Is Mylan’s Generics Segment Doing?
Mylan’s (MYL) 3Q16 revenues were mainly driven by a 17.0% rise in sales for its Generics segment. The segment reported $2.6 billion in sales in 3Q16.
- ETF.com•10 months ago
Least Popular ETFs Of The Year
As noted in separate articles on ETF.com this month, annual flows into U.S.-listed exchange-traded funds are in record territory, and it's the giant broad market ETFs―such as the SPDR S&P 500 ETF (SPY)―that have been the most popular funds in 2016.
- Market Realist•11 months ago
Uterine Fibroids Segment May Offer Opportunity for NBIX
According to MarketScan and Truven Health Analytics, approximately 9 million women in the US need therapy for symptoms related to uterine fibroids (or UF).
- Market Realist•11 months ago
Baxter’s Latest Dividend and Share Repurchase Authorization
Baxter International (BAX) announced a quarterly cash dividend of $0.13 per share on November 8, 2016.
- Market Realist•11 months ago
Inside the Double-Digit Fall for Mallinckrodt’s Specialty Generics Business in 2016
Specialty Generics' contribution to Mallinckrodt's net sales fell by 18% to $1 billion in 2016. The business had a 31% share in total net sales in 2016.
- Market Realist•11 months ago
What Is Donald Trump’s Seven-Point Health Plan?
Trump’s healthcare agenda During his campaign, Trump came up with a seven-point plan for the healthcare industry. In this plan, he proposed to repeal the Affordable Care Act. Although a complete…
- Market Realist•11 months ago
How Could Trump’s Presidency Affect Hospitals and Insurance?
The effects of repealing Obamacare Donald Trump is definitely not in favor of the Affordable Care Act, known as Obamacare. As he wants to repeal the act completely and replace it…
- Zacks•11 months ago
TIPS Bond & Health Care: 2 ETFs Trading with Outsized Volume
TIP and FXH saw massive volumes in Wednesday's trading session.
- Market Realist•last year
How EW’s Gross Profit Margins Were Affected in 3Q16
Edwards Lifesciences (EW) reported falling revenue in 3Q16. Its gross profit margin fell and was reported to be ~72.8% of its total revenue, compared to ~76.2% in 2Q16.
- ETF.com•last year
Picking The Right Sectors For 2017
Rob Stein is all about the power of economic fundamentals. Building ETF portfolios that are widely used by advisors and investors alike, Stein and his team at Astor Investment Management are constantly taking the economy’s temperature and adjusting exposures accordingly. Today the firm manages nearly $2 billion in assets. Stein tells us what sectors he likes and doesn’t like for 2017, and why sector rotation is a good strategy to consider.
- Market Realist•last year
What Are the Signs of a Bear Market?
Signs of bear markets After outlining why he thinks bull markets in the US are more common than investors think, Richard Bernstein went on to discuss the signs of bear…
